{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04616196: Phase 1/Phase 2 Interventional Completed Head and Neck Squamous Cell Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:tuvonralimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00523159: Phase 2 Interventional Completed Renal Cell Carcinoma
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:melredableukin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03989531: Phase 2/Phase 3 Interventional Completed Cardiogenic Shock
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
USAN:GEMIBOTULINUMTOXIN A [USAN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03972657: Phase 1/Phase 2 Interventional Recruiting Metastatic Castration-resistant Prostate Cancer (mCRPC)
(2019)
Source URL:
Class:
PROTEIN